Physician profile
Dineshkumar Patel
NPI 1316160161
$11,187.17
in general payments reported to CMS, 2019-2025
35 companies · $2,699 in 2025
The $2,699 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,333 · 2020: $529 · 2021: $1,016 · 2022: $1,513 · 2023: $1,425 · 2024: $2,672 · 2025: $2,699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,940 · Travel and Lodging: $1,855.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,939.95 |
| Travel and Lodging | $1,855.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,785.13 | 2021-2025 | Triclip, Mitraclip, Amplatzer Amulet |
| Medtronic, INC. | $1,443.99 | 2021-2025 | Corevalve Evolut R, Turbohawk |
| Edwards Lifesciences Corporation | $1,398.73 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal |
| Novartis Pharmaceuticals Corporation | $775.60 | 2019-2025 | |
| Boston Scientific Corporation | $747.66 | 2019-2025 | Avvigo Guidance System, Watchman Flx, Watchman Access System |
| Amgen INC. | $533.60 | 2019-2025 | Repatha, Repatha |
| Medtronic Vascular, INC. | $390.49 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $353.05 | 2019-2024 | Xarelto |
| Shockwave Medical, INC | $352.15 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $323.92 | 2024-2025 | Impella |
| Pfizer INC. | $309.13 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $301.32 | 2019-2024 | Farxiga |
| Biotronik INC. | $295.35 | 2020-2023 | Biomonitor |
| Biosense Webster, INC. | $279.87 | 2022-2024 | Nuvision Ice Catheter, Na |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $238.61 | 2019-2025 | Lifevest |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $224.64 | 2020-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $208.01 | 2022-2024 | Verquvo |
| W. L. Gore & Associates, INC. | $202.14 | 2022-2025 | Gore Cardioform Septal Occluder |
| Cvrx, INC. | $194.75 | 2022-2025 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $119.71 | 2021-2025 | Camzyos, Eliquis |
| Celonova Biosciences, INC. | $112.02 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $104.57 | 2023-2024 | Inpefa |
| Opsens INC. | $80.59 | 2019 | |
| Esperion Therapeutics, INC. | $68.38 | 2022-2025 | Nexletol |
| Actelion Pharmaceuticals US, INC. | $57.32 | 2022-2025 | Uptravi |
| Daiichi Sankyo INC. | $54.50 | 2023 | Injectafer |
| Cardiva Medical, INC. | $51.78 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $42.06 | 2020-2023 | |
| Siemens Medical Solutions USA, INC. | $27.86 | 2022 | |
| Cardinal Health 200 LLC | $24.22 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.32 | 2021 | |
| Acist Medical Systems, INC. | $19.57 | 2019 | |
| Amarin Pharma, INC. | $18.81 | 2021 | |
| Novo Nordisk INC | $15.34 | 2023 | Ozempic |
| Cardiovascular Systems INC. | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dineshkumar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.